IMPROVEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PURPOSES

Recombinant human serum albumin (OsrHSA) has emerged as a major innovation in the sector of biopharmaceuticals, presenting promising progress across different medical and industrial apps. With its structural similarity to Obviously derived human serum albumin, OsrHSA offers a safer, more trusted option for therapeutic use, especially in drug delive